20 AIDX
NASDAQ AIDX
$0.51 +0.01 (+1.06%)
At close: Aug 20, 2026 · 2:07 PM UTC

20 (AIDX) Intangibles (2024 - 2026)

20's (AIDX) quarterly Intangibles came in at $206801.0 in Q1 2026, up 2.24% on a QoQ basis from $202264.0 in Q4 2025.

20 (AIDX) Intangibles (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Intangibles data on file, last reported at $206801.0 in Q1 2026.

  • Quarterly Intangibles changed N/A year-over-year to $206801.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $206801.0 (changed N/A YoY) and the FY2025 annual result came in at $202264.0, down 1.59% from the prior year.
  • Intangibles grew to $206801.0 in Q1 2026, from $202264.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $206801.0 in Q1 2026 to a low of $202264.0 in Q4 2025.
  • A 3-year average of $204864.7 and a median of $205529.0 in 2024 frame the typical range for Intangibles.
  • The widest YoY moves for Intangibles: up 1.59% in 2025, down 1.59% in 2025.
  • Tracing AIDX's Intangibles over 3 years: stood at $205529.0 in 2024, then fell by 1.59% to $202264.0 in 2025, then increased by 2.24% to $206801.0 in 2026.
  • The last three Intangibles figures came in at $206801.0 (Q1 2026), $202264.0 (Q4 2025), and $205529.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn 17.21 Bn
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn 5.74 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn 10.15 Bn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn 6.92 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 1.38 Bn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn 101.60 Mn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn 1.89 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 2.98 Bn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn 1.56 Bn
10 20 5.55 Mn 1.00 Mn 304,727.00 205,985.00

Historic Data

Download Data
DateValue
Mar 31, 2026 206,801.00
Dec 31, 2025 202,264.00
Dec 31, 2024 205,529.00